AXACEF

This brand name is authorized in Nigeria.

Active ingredients

The drug AXACEF contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-5980	Tablet	Axacef 250 mg Tablet TAB 250 mg	Each tablet contains: Cefuroxime (as Cefuroxime Axetil) 250 mg	01/03/2021
04-6027	Tablet	Axacef 500 mg Tablets TAB 500 mg 1 x 10's (in blister)	Tablet	28/01/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	56091, 57855
NG	Registered Drug Product Database	04-5980, 04-6027